Adenosine Targeting as a New Strategy to Decrease Glioblastoma Aggressiveness

SIMPLE SUMMARY: Given the rising mortality rate caused by GBM, current therapies do not appear to be effective in counteracting tumor progression. The role of adenosine and its interaction with specific receptor subtypes in various physiological functions has been studied for years. Only recently, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Bova, Valentina, Filippone, Alessia, Casili, Giovanna, Lanza, Marika, Campolo, Michela, Capra, Anna Paola, Repici, Alberto, Crupi, Lelio, Motta, Gianmarco, Colarossi, Cristina, Chisari, Giulia, Cuzzocrea, Salvatore, Esposito, Emanuela, Paterniti, Irene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406358/
https://www.ncbi.nlm.nih.gov/pubmed/36011024
http://dx.doi.org/10.3390/cancers14164032

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9406358/
https://www.ncbi.nlm.nih.gov/pubmed/36011024
http://dx.doi.org/10.3390/cancers14164032

Ejemplares similares